Tag: Chemotherapy

For most patients, definitive treatment with combined modality therapy is recommended

Physical health decline greater for survivors receiving chemotherapy compared with endocrine therapy alone within two years of diagnosis

Adding nivolumab to neoadjuvant chemotherapy significantly increases pathological complete response rates

Significant and clinically relevant improvement seen in objective response rate with encorafenib + cetuximab plus mFOLFOX6

Among patients with chemotherapy-induced peripheral neuropathy, those treated with platinum-based agents, taxanes had highest prevalence

Improved survival seen with perioperative chemotherapy with FLOT versus preoperative chemoradiotherapy

Glucarpidase associated with 2.70-fold increased odds of kidney recovery in methotrexate-acute kidney injury

Modest absolute reduction in use observed, which increased during peak of shortage; no difference seen in mortality during shortage

Addition of camrelizumab improves pathological complete response in early or locally advanced triple negative breast cancer

All patients receiving surgery/radiotherapy alone or with chemotherapy had improvement or stability of alopecia with LDOM